Association of maternal diabetes with neurodevelopmental disorders: autism spectrum disorders, attention-deficit/hyperactivity disorder and intellectual disability

Autor: Sixian Zhao, Christina Dalman, Renee M. Gardner, Shuyun Chen, Håkan Karlsson
Rok vydání: 2020
Předmět:
Male
Pediatrics
medicine.medical_specialty
endocrine system diseases
Autism Spectrum Disorder
type 2 diabetes mellitus
Epidemiology
Offspring
Population
Cohort Studies
03 medical and health sciences
0302 clinical medicine
Pregnancy
attention-deficit hyperactivity disorder
mental disorders
Intellectual disability
medicine
Humans
Attention deficit hyperactivity disorder
AcademicSubjects/MED00860
030212 general & internal medicine
education
Sweden
education.field_of_study
business.industry
Type 2 Diabetes Mellitus
General Medicine
Autism spectrum disorders
medicine.disease
gestational diabetes mellitus
Gestational diabetes
Diabetes
Gestational

Diabetes Mellitus
Type 2

Attention Deficit Disorder with Hyperactivity
Neurodevelopmental Disorders
intellectual disability
Autism spectrum disorder
Autism
Female
ADHD and ASD
business
type 1 diabetes mellitus
030217 neurology & neurosurgery
Zdroj: International Journal of Epidemiology
ISSN: 1464-3685
0300-5771
Popis: Background Maternal diabetes has been associated with a risk of neurodevelopmental disorders (NDDs) in offspring, though the common co-occurrence of autism spectrum disorders (ASD), attention-deficit/hyperactivity disorder (ADHD) and intellectual disability (ID) is rarely considered, nor is the potential for confounding by shared familial factors (e.g. genetics). Methods This population-based cohort study used data from Psychiatry Sweden, a linkage of Swedish national registers, to follow 2 369 680 individuals born from 1987 to 2010. We used population-averaged logit models to examine the association between exposure to maternal type 1 diabetes mellitus (T1DM), pre-gestational type 2 diabetes mellitus (T2DM) or gestational diabetes mellitus (GDM), and odds of NDDs in offspring. Subgroup analysis was then performed to investigate the timings of GDM diagnosis during pregnancy and its effect on the odds of NDDs in offspring. We compared these results to models considering paternal lifetime T1DM and T2DM as exposures. Results Overall, 45 678 individuals (1.93%) were diagnosed with ASD, 20 823 (0.88%) with ID and 102 018 (4.31%) with ADHD. All types of maternal diabetes were associated with odds of NDDs, with T2DM most strongly associated with any diagnosis of ASD (odds ratioadjusted 1.37, 95% confidence interval 1.03–1.84), ID (2.09, 1.53–2.87) and ADHD (1.43, 1.16–1.77). Considering common co-morbid groups, the associations were strongest between maternal diabetes and diagnostic combinations that included ID. Paternal T1DM and T2DM diagnoses were also associated with offspring NDDs, but these associations were weaker than those with maternal diabetes. Diagnosis of GDM between 27 and 30 weeks of gestation was generally associated with the greatest risk of NDDs in offspring, with the strongest associations for outcomes that included ID. Conclusion The association of maternal diabetes with NDDs in offspring varies depending on the co-morbid presentation of the NDDs, with the greatest odds associated with outcomes that included ID. Results of paternal-comparison studies suggest that the above associations are likely to be partly confounded by shared familial factors, such as genetic liability.
Databáze: OpenAIRE